• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磷酸肽富集结合无标记定量质谱法研究前列腺癌中的磷酸化蛋白质组

Phosphopeptide Enrichment Coupled with Label-free Quantitative Mass Spectrometry to Investigate the Phosphoproteome in Prostate Cancer.

作者信息

Cheng Larry C, Li Zhen, Graeber Thomas G, Graham Nicholas A, Drake Justin M

机构信息

Graduate Program in Cellular and Molecular Pharmacology, School of Graduate Studies, Rutgers University, The State University of New Jersey; Graduate Program in Quantitative Biomedicine, School of Graduate Studies, Rutgers University, The State University of New Jersey.

Department of Medicine, Division of Medical Oncology, Rutgers Robert Wood Johnson Medical School.

出版信息

J Vis Exp. 2018 Aug 2(138):57996. doi: 10.3791/57996.

DOI:10.3791/57996
PMID:30124664
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6126612/
Abstract

Phosphoproteomics involves the large-scale study of phosphorylated proteins. Protein phosphorylation is a critical step in many signal transduction pathways and is tightly regulated by kinases and phosphatases. Therefore, characterizing the phosphoproteome may provide insights into identifying novel targets and biomarkers for oncologic therapy. Mass spectrometry provides a way to globally detect and quantify thousands of unique phosphorylation events. However, phosphopeptides are much less abundant than non-phosphopeptides, making biochemical analysis more challenging. To overcome this limitation, methods to enrich phosphopeptides prior to the mass spectrometry analysis are required. We describe a procedure to extract and digest proteins from tissue to yield peptides, followed by an enrichment for phosphotyrosine (pY) and phosphoserine/threonine (pST) peptides using an antibody-based and/or titanium dioxide (TiO2)-based enrichment method. After the sample preparation and mass spectrometry, we subsequently identify and quantify phosphopeptides using liquid chromatography-mass spectrometry and analysis software.

摘要

磷酸化蛋白质组学涉及对磷酸化蛋白质的大规模研究。蛋白质磷酸化是许多信号转导途径中的关键步骤,并受到激酶和磷酸酶的严格调控。因此,对磷酸化蛋白质组进行表征可能有助于识别肿瘤治疗的新靶点和生物标志物。质谱分析法提供了一种全局检测和量化数千种独特磷酸化事件的方法。然而,磷酸化肽段的丰度远低于非磷酸化肽段,这使得生化分析更具挑战性。为克服这一限制,需要在质谱分析之前采用富集磷酸化肽段的方法。我们描述了一种从组织中提取和消化蛋白质以产生肽段的程序,随后使用基于抗体和/或基于二氧化钛(TiO2)的富集方法富集磷酸化酪氨酸(pY)和磷酸化丝氨酸/苏氨酸(pST)肽段。在样品制备和质谱分析之后,我们随后使用液相色谱-质谱联用仪和分析软件对磷酸化肽段进行鉴定和定量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1fe/6126612/6472fc28c412/jove-138-57996-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1fe/6126612/fef11c0487a6/jove-138-57996-0.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1fe/6126612/1275d64a2c15/jove-138-57996-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1fe/6126612/b5383aac8d48/jove-138-57996-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1fe/6126612/7e98686f26d8/jove-138-57996-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1fe/6126612/6472fc28c412/jove-138-57996-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1fe/6126612/fef11c0487a6/jove-138-57996-0.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1fe/6126612/1275d64a2c15/jove-138-57996-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1fe/6126612/b5383aac8d48/jove-138-57996-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1fe/6126612/7e98686f26d8/jove-138-57996-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1fe/6126612/6472fc28c412/jove-138-57996-4.jpg

相似文献

1
Phosphopeptide Enrichment Coupled with Label-free Quantitative Mass Spectrometry to Investigate the Phosphoproteome in Prostate Cancer.磷酸肽富集结合无标记定量质谱法研究前列腺癌中的磷酸化蛋白质组
J Vis Exp. 2018 Aug 2(138):57996. doi: 10.3791/57996.
2
Combining Metabolic ¹⁵N Labeling with Improved Tandem MOAC for Enhanced Probing of the Phosphoproteome.将代谢¹⁵N标记与改进的串联MOAC相结合,以增强对磷酸化蛋白质组的探测。
Methods Mol Biol. 2015;1306:81-96. doi: 10.1007/978-1-4939-2648-0_6.
3
Optimization of titanium dioxide and immunoaffinity-based enrichment procedures for tyrosine phosphopeptide using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.使用基质辅助激光解吸/电离飞行时间质谱法对基于二氧化钛和免疫亲和的酪氨酸磷酸肽富集程序进行优化。
Anal Bioanal Chem. 2015 Feb;407(5):1343-56. doi: 10.1007/s00216-014-8352-0. Epub 2014 Dec 7.
4
Off-line high-pH reversed-phase fractionation for in-depth phosphoproteomics.用于深入磷酸化蛋白质组学的离线高pH反相分级分离
J Proteome Res. 2014 Dec 5;13(12):6176-86. doi: 10.1021/pr500893m. Epub 2014 Nov 4.
5
Phosphotyrosine Biased Enrichment of Tryptic Peptides from Cancer Cells by Combining pY-MIP and TiO Affinity Resins.通过将 pY-MIP 和 TiO2 亲和树脂相结合,从癌细胞中进行磷酸酪氨酸偏置的胰蛋白酶肽富集。
Anal Chem. 2017 Nov 7;89(21):11332-11340. doi: 10.1021/acs.analchem.7b02091. Epub 2017 Oct 25.
6
Comprehensive profiling of phosphopeptides based on anion exchange followed by flow-through enrichment with titanium dioxide (AFET).基于阴离子交换的磷酸肽综合分析,随后用 TiO2(AFET)进行在线富集。
J Proteome Res. 2010 Sep 3;9(9):4585-94. doi: 10.1021/pr100632h.
7
Macroporous reversed-phase separation of proteins combined with reversed-phase separation of phosphopeptides and tandem mass spectrometry for profiling the phosphoproteome of MDA-MB-231 cells.蛋白质的大孔反相分离与磷酸肽的反相分离及串联质谱联用,用于分析MDA-MB-231细胞的磷酸化蛋白质组。
Electrophoresis. 2014 Dec;35(24):3479-86. doi: 10.1002/elps.201300586. Epub 2014 Jul 28.
8
Isotope-labeling and affinity enrichment of phosphopeptides for proteomic analysis using liquid chromatography-tandem mass spectrometry.使用液相色谱-串联质谱法进行蛋白质组学分析时磷酸化肽段的同位素标记和亲和富集
Methods Mol Biol. 2009;564:303-21. doi: 10.1007/978-1-60761-157-8_17.
9
Sequential Fe3O4/TiO2 enrichment for phosphopeptide analysis by liquid chromatography/tandem mass spectrometry.采用 Fe3O4/TiO2 顺序富集法,通过液相色谱/串联质谱法进行磷酸肽分析。
Rapid Commun Mass Spectrom. 2010 May 30;24(10):1467-74. doi: 10.1002/rcm.4541.
10
Mass Spectrometry-Based Proteomics for Analysis of Hydrophilic Phosphopeptides.基于质谱的蛋白质组学分析亲水磷酸肽。
Methods Mol Biol. 2021;2259:247-257. doi: 10.1007/978-1-0716-1178-4_16.

引用本文的文献

1
Dual inhibition of ATR and DNA-PKcs radiosensitizes ATM-mutant prostate cancer.对ATR和DNA-PKcs的双重抑制使ATM突变型前列腺癌对放疗敏感。
Oncogene. 2025 Mar 21. doi: 10.1038/s41388-025-03343-x.
2
Unraveling the Global Proteome and Phosphoproteome of Prostate Cancer Patient-Derived Xenografts.解析前列腺癌患者来源异种移植的全蛋白质组和磷酸化蛋白质组。
Mol Cancer Res. 2024 May 2;22(5):452-464. doi: 10.1158/1541-7786.MCR-23-0976.
3
Advances and Trends in Omics Technology Development.组学技术发展的进展与趋势

本文引用的文献

1
Benchmarking common quantification strategies for large-scale phosphoproteomics.大规模磷酸化蛋白质组学常见定量策略的基准测试
Nat Commun. 2018 Mar 13;9(1):1045. doi: 10.1038/s41467-018-03309-6.
2
Cancer statistics, 2018.癌症统计数据,2018 年。
CA Cancer J Clin. 2018 Jan;68(1):7-30. doi: 10.3322/caac.21442. Epub 2018 Jan 4.
3
Metabolic reprogramming ensures cancer cell survival despite oncogenic signaling blockade.尽管致癌信号传导被阻断,但代谢重编程可确保癌细胞存活。
Front Med (Lausanne). 2022 Jul 1;9:911861. doi: 10.3389/fmed.2022.911861. eCollection 2022.
4
Cabozantinib and dasatinib synergize to induce tumor regression in non-clear cell renal cell carcinoma.卡博替尼和达沙替尼协同作用诱导非透明细胞肾细胞癌肿瘤消退。
Cell Rep Med. 2021 May 7;2(5):100267. doi: 10.1016/j.xcrm.2021.100267. eCollection 2021 May 18.
5
Phosphoproteomic quantitation and causal analysis reveal pathways in GPVI/ITAM-mediated platelet activation programs.磷酸化蛋白质组定量和因果分析揭示了 GPVI/ITAM 介导的血小板激活程序中的途径。
Blood. 2020 Nov 12;136(20):2346-2358. doi: 10.1182/blood.2020005496.
6
Targeting RET Kinase in Neuroendocrine Prostate Cancer.针对神经内分泌前列腺癌中的 RET 激酶。
Mol Cancer Res. 2020 Aug;18(8):1176-1188. doi: 10.1158/1541-7786.MCR-19-1245. Epub 2020 May 27.
7
Multilevel Regulation of Peroxisomal Proteome by Post-Translational Modifications.过 翻译后修饰对过氧化物酶体蛋白质组的多级调控。
Int J Mol Sci. 2019 Oct 1;20(19):4881. doi: 10.3390/ijms20194881.
Genes Dev. 2017 Oct 15;31(20):2067-2084. doi: 10.1101/gad.305292.117. Epub 2017 Nov 14.
4
Design and synthesis of an immobilized metal affinity chromatography and metal oxide affinity chromatography hybrid material for improved phosphopeptide enrichment.用于改进磷酸肽富集的固定化金属亲和色谱与金属氧化物亲和色谱混合材料的设计与合成。
J Chromatogr A. 2017 Jul 7;1505:56-62. doi: 10.1016/j.chroma.2017.05.025. Epub 2017 May 10.
5
Phosphoproteomics of Primary Cells Reveals Druggable Kinase Signatures in Ovarian Cancer.原代细胞的磷酸化蛋白质组学揭示了卵巢癌中可成药的激酶特征。
Cell Rep. 2017 Mar 28;18(13):3242-3256. doi: 10.1016/j.celrep.2017.03.015.
6
Assessment of Label-Free Quantification in Discovery Proteomics and Impact of Technological Factors and Natural Variability of Protein Abundance.发现蛋白质组学中无标记定量分析以及技术因素和蛋白质丰度自然变异的影响
J Proteome Res. 2017 Apr 7;16(4):1410-1424. doi: 10.1021/acs.jproteome.6b00645. Epub 2017 Feb 28.
7
Phosphoproteome Integration Reveals Patient-Specific Networks in Prostate Cancer.磷酸化蛋白质组整合揭示前列腺癌患者特异性网络。
Cell. 2016 Aug 11;166(4):1041-1054. doi: 10.1016/j.cell.2016.07.007. Epub 2016 Aug 4.
8
Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer.人类高级别浆液性卵巢癌的综合蛋白质基因组特征分析
Cell. 2016 Jul 28;166(3):755-765. doi: 10.1016/j.cell.2016.05.069. Epub 2016 Jun 29.
9
Proteogenomics connects somatic mutations to signalling in breast cancer.蛋白质基因组学将体细胞突变与乳腺癌中的信号传导联系起来。
Nature. 2016 Jun 2;534(7605):55-62. doi: 10.1038/nature18003. Epub 2016 May 25.
10
Proteomics Quality Control: Quality Control Software for MaxQuant Results.蛋白质组学质量控制:用于MaxQuant结果的质量控制软件
J Proteome Res. 2016 Mar 4;15(3):777-87. doi: 10.1021/acs.jproteome.5b00780. Epub 2015 Dec 28.